普华和顺：四川睿健医疗上半年归母净利7292.36万元 同比增长28.98%

Group 1 - The core viewpoint of the article highlights the financial performance of Sichuan Ruijian Medical, a subsidiary of PwC and Shun (01358), for the first half of 2025, showcasing significant growth in both revenue and net profit [1] Group 2 - Sichuan Ruijian Medical reported revenue of approximately 298 million yuan, representing a year-on-year increase of 44.68% [1] - The net profit attributable to shareholders of Sichuan Ruijian Medical was approximately 72.92 million yuan, reflecting a year-on-year growth of 28.98% [1]